Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model
An Tanghe, Tom Van Dooren(KU Leuven), Annelies Termont(KU Leuven), Gerard Griffioen(KU Leuven), Louise A. Scrocchi(Amorfix (Canada)), Stephan Schilling(Probiodrug (Germany)), Hans‐Ulrich Demuth(Probiodrug (Germany)), Fred Van Leuven(KU Leuven), Pascal Merchiers(Ablynx (Belgium))
Cited by 30
Related Papers
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
|Proceedings of the National Academy of Sciences|1999|523
Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
|Molecular and Cellular Biology|2012|473